So it looks as if Enigma Therapeutics Limited (Enigma), paid...

So it looks as if Enigma Therapeutics Limited (Enigma), paid $100k for the rights in 2012, and in 2013 sold out to Oncosil (as it is now known) for well over $1m.

Someone made a very nice earner out of that one.

Was / is there any connection between the two companies - directors / large shareholding etc? Has any research been done on who owned Enigma and possible connections?

I also note
'The early stages of the Oncosil  manufacturing process are on “cold” (ie non -radioactive) materials and partners are responsible for the atomisation, size definition and nanostructuring of the 30 micron particles and for the ( 32 P), activation, formulation, packaging and distribution of Oncosil  to trial sites.'

Does this mean that the phase 2 trials were from material made on the bench, and not a robust manufacturing process through to a deliverable product?

David James is a manufacturing specialist with SRX history, so hopefully he has this covered by now? Sorry if I have missed something but it there any confirmation that OSL have cracked the manufacturing process including the nanostructuring?

This is like a Dan Brown novel, and the layers have to be peeled off to expose the inner core - all interesting stuff.